Full Text (PDF)

Total Page:16

File Type:pdf, Size:1020Kb

Full Text (PDF) 150 Journal of Pharmaceutical, Chemical and Biological Sciences ISSN: 2348-7658 Impact Factor (GIF): 0.615 Impact Factor (SJIF): 2.092 June-August 2015; 3(2):150-155 Available online at http://www.jpcbs.info Review Article Review on Onchomycoses: Definition, Causes, Treatment and Prevention Alaa M. Hasan Department of Biology, Collage of Science, University of Baghdad, Iraq *Corresponding Author: Alaa M. Hasan, Department of Biology, Collage of Science, University of Baghdad, Iraq Received: 01 June 2015 Revised: 09 June 2015 Accepted: 11 June 2015 ABSTRACT Onychomycosis is a fungal infection of the nail unit, more common in toenails than in fingernails, There are 4 to 5 subtypes related to the method of fungal invasion of the nail unit, the most common being distal lateral subungual onychomycosis. Onychomycosis can cause pain, discomfort, and disfigurement and may produce serious physical and occupational limitations, as well as reducing quality of life. Trichophyton rubrum is the most common dermatophytes involved in onychomycosis. Other dermatophytes that may be involved are T. interdigitale, Epidermophyton floccosum, T. violaceum, Microsporum gypseum, T. tonsurans and T. soudanense. Candida spp. mainly causes fingernail onychomycosis in people whose hands are often submerged in water. Other molds more commonly affect people older than 60 years, and their presence in the nail reflects a slight weakening in the nail's ability to defend itself against fungal invasion. Keyword: Onychomycosis; dermatophytes; Candida; antifungals and fungal infection INTRODUCTION Onychomycosis is the most common nail infection that affects the toenails or the disease, accounting for about half of nail fingernails. Onychomycosis may involve any pathologies [1], if untreated, it can lead to pain, component of the nail unit, including the nail discomfort in shoes, infection, and subungual matrix, nail bed, or nail plate. Such infection ulceration. There may also be increased self- isnot life threatening, but it can cause pain, consciousness of the disfigured nails, which can discomfort, and disfigurement and may have psychosocial and emotional effects [2]. produce serious physical and occupational Onychomycosis (OM) refers to a fungal limitations. Psychosocial and emotional effects J Pharm Chem Biol Sci, June-August 2015; 3(2):150-155 Alaa M. Hasan 151 resulting from onychomycosis are widespread reported to be 2-13% in North America [7]. A and may have a significant impact on quality of multicenter survey in Canada showed the life [3]. Onychomycosis in patients who are prevalence of onychomycosis at 6.5% [8]. immunocompromised is associated with Studies in the United Kingdom, Spain, and increased severity and morbidity. Lesions may Finland found prevalence rates of appear atypical and require more aggressive onychomycosis to be 3-8% [4]. Onychomycosis management compared with the healthy affects persons of all races, and it affects males population. Proximal subungual (proximal more commonly than females, and is associated subungual onychomycosis) involvement is much with a family history of this infection. However, more prevalent in patients with HIV infection studies indicate that adults are 30 times more than in those without HIV infection. In this likely to have onychomycosis than children. population, white superficial onychomycosis is Onychomycosis has been reported to occur in more commonly caused by Trichophyton 2.6% of children younger than 18 years but as rubrum, rather than Trichophyton many as 90% of elderly people [4]. mentagrophytes. [4]. Diabetic patients are at The main subtypes of onychomycosis are distal increased risk of infectious complications. The lateral subungual onychomycosis (DLSO), white diabetic foot may lead to serious complications superficial onychomycosis (WSO), proximal associated with onychomycosis. Peripheral subungual onychomycosis (PSO), endonyx neuropathy and sensory loss may lead to onychomycosis (EO), and candidal increased trauma without pain in patients with onychomycosis. diabetes. Bacterial colonization and vascular Patients may have a combination of these insufficiency may exacerbate the problem and subtypes. Total dystrophic onychomycosis may lead to serious sequelae [2]. refers to the most advanced form of any Aging is the most common risk factor for subtype [4]. The pathogenesis of onychomycosis due to diminished blood onychomycosis depends on the clinical subtype. circulation, longer exposure to fungi, and nails In distal lateral subungual onychomycosis, the which grow more slowly and thicken, increasing most common form of onychomycosis, the susceptibility to infection. Onychomycosis in fungus spreads from plantar skin and invades elderly people is complicated by diseases (eg, the nail bed via the hyponychium. Inflammation poor vision, arthritis) that prevent optimal foot occurring in these areas of the nail apparatus care. Nail changes are much more common in causes the typical physical signs of distal lateral elderly persons and often involve the fingernails subungual onychomycosis. In contrast, white and the toenails. The potential for drug-drug superficial onychomycosis is a rarer interactions is more evident and must be presentation caused by direct invasion of the addressed before initiating oral therapy [5]. surface of the nail plate. In proximal subungual Onychomycosis accounts for half of all nail onychomycosis, the least common subtype, disorders, and it is the most common nail fungi penetrate the nail matrix via the proximal disease in adults. Toenails are much more likely nail fold and colonize the deep portion of to be infected than fingernails. proximal nail plate. Endonyx onychomycosis is a Thirty percent of patients with a cutaneous variant of distal lateral subungual fungal infection also have onychomycosis. The onychomycosis in which the fungi infect the nail incidence of onychomycosis has been via the skin and directly invade the nail plate. increasing, owing to such factors as diabetes, Total dystrophic onychomycosis involves the immunosuppression, and increasing age [6]. entire nail unit [4]. People with onychomycosis The incidence of onychomycosis has been may experience significant psychosocial J Pharm Chem Biol Sci, June-August 2015; 3(2):150-155 Alaa M. Hasan 152 problems due to the appearance of the nail, onycholysis, in these patients Candida is only a particularly when fingers – which are always secondary colonizer. In chronic mucocutaneous visible – rather than toenails are affected [9]. candidiasis, the yeast infects the nail plate and Diagnosis of onychomycosis is generally made eventually the proximal and lateral nail folds based on its typical clinical appearance. When [4]. Other molds more commonly affect people the diagnosis is in doubt, laboratory testing older than 60 years, and their presence in the with potassium hydroxide (KOH 10%) nail reflects a slight weakening in the nail's preparation and also periodic acid Schiff testing ability to defend itself against fungal invasion of the nail is recommended [10]. [6]. On the other hand onychomycosis may occur without tinea pedis in only a couple of CAUSES scenarios: if a pedicure has inoculated the The causative pathogens of onychomycosis fungus directly into the nail, or if the patient include dermatophytes, Candida, and has used infected clippers. Older patients will nondermatophytic molds [11]. Dermatophytes often tell you that they don’t have tinea pedis, are the fungi most commonly responsible for until you ask them to take their socks off. They onychomycosis in the temperate western assume incorrectly that foot dryness is normal countries, the most common dermatophytes [13]. species are Trichophyton rubrum. Other dermatophytes that may be involved are T. DIAGNOSES interdigitale, Epidermophyton floccosum, T. To avoid misdiagnosis as nail psoriasis, lichen violaceum, Microsporum gypseum, T. planus, contact dermatitis, nail bed tumors such tonsurans, and T. soudanense. A common as melanoma, trauma, or yellow nail syndrome, outdated name that may still be reported by laboratory confirmation may be necessary [11]. medical laboratories is Trichophyton The three main approaches are potassium mentagrophytes for T. interdigitale. The name hydroxide smear, culture and histology [11]. T. mentagrophytes is now restricted to the This involves microscopic examination and agent of favus skin infection of the mouse; culture of nail scrapings or clippings. Recent though this fungus may be transmitted from results indicate the most sensitive diagnostic mice and their danders to humans, it generally approaches are direct smear combined with infects skin and not nails. While Candida and histological examination [14], and nail plate nondermatophytic molds particular members of biopsy using periodic acid-Schiff stain [15]. To the mold generation Scytalidium (name recently reliably identify nondermatophyte molds, changed to Neoscytalidium), Scopulariopsis, and several samples may be necessary [16]. Aspergillus, are more frequently involved in the tropics and subtropics with a hot and humid TREATMENT climate [12]. Candida spp. mainly causes Treatment of onychomycosis may consist of fingernail onychomycosis in people whose either topical or oral antifungal medications hands are often submerged in water. according to the severity of infection [17]. In Furthermore the process of nail invasion by general, topical agents should be used as Candida is not common because the yeast monotherapy only in cases involving less than needs
Recommended publications
  • Estimated Burden of Serious Fungal Infections in Ghana
    Journal of Fungi Article Estimated Burden of Serious Fungal Infections in Ghana Bright K. Ocansey 1, George A. Pesewu 2,*, Francis S. Codjoe 2, Samuel Osei-Djarbeng 3, Patrick K. Feglo 4 and David W. Denning 5 1 Laboratory Unit, New Hope Specialist Hospital, Aflao 00233, Ghana; [email protected] 2 Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, P.O. Box KB-143, Korle-Bu, Accra 00233, Ghana; [email protected] 3 Department of Pharmaceutical Sciences, Faculty of Health Sciences, Kumasi Technical University, P.O. Box 854, Kumasi 00233, Ghana; [email protected] 4 Department of Clinical Microbiology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi 00233, Ghana; [email protected] 5 National Aspergillosis Centre, Wythenshawe Hospital and the University of Manchester, Manchester M23 9LT, UK; [email protected] * Correspondence: [email protected] or [email protected] or [email protected]; Tel.: +233-277-301-300; Fax: +233-240-190-737 Received: 5 March 2019; Accepted: 14 April 2019; Published: 11 May 2019 Abstract: Fungal infections are increasingly becoming common and yet often neglected in developing countries. Information on the burden of these infections is important for improved patient outcomes. The burden of serious fungal infections in Ghana is unknown. We aimed to estimate this burden. Using local, regional, or global data and estimates of population and at-risk groups, deterministic modelling was employed to estimate national incidence or prevalence. Our study revealed that about 4% of Ghanaians suffer from serious fungal infections yearly, with over 35,000 affected by life-threatening invasive fungal infections.
    [Show full text]
  • Introduction
    Notes Introduction 1. In the book, we use the terms ‘fungal infections’ and ‘mycoses’ (or singular fungal infection and mycosis) interchangeably, mostly following the usage of our historical actors in time and place. 2. The term ‘ringworm’ is very old and came from the circular patches of peeled, inflamed skin that characterised the infection. In medicine at least, no one understood it to be associated with worms of any description. 3. Porter, R., ‘The patient’s view: Doing medical history from below’, Theory and Society, 1985, 14: 175–198; Condrau, F., ‘The patient’s view meets the clinical gaze’, Social History of Medicine, 2007, 20: 525–540. 4. Burnham, J. C., ‘American medicine’s golden age: What happened to it?’, Sci- ence, 1982, 215: 1474–1479; Brandt, A. M. and Gardner, M., ‘The golden age of medicine’, in Cooter, R. and Pickstone, J. V., eds, Medicine in the Twentieth Century, Amsterdam, Harwood, 2000, 21–38. 5. The Oxford English Dictionary states that the first use of ‘side-effect’ was in 1939, in H. N. G. Wright and M. L. Montag’s textbook: Materia Med Pharma- col & Therapeutics, 112, when it referred to ‘The effects which are not desired in any particular case are referred to as “side effects” or “side actions” and, in some instances, these may be so powerful as to limit seriously the therapeutic usefulness of the drug.’ 6. Illich, I., Medical Nemesis: The Expropriation of Health, London, Calder & Boyars, 1975. 7. Beck, U., Risk Society: Towards a New Society, New Delhi, Sage, 1992, 56 and 63; Greene, J., Prescribing by Numbers: Drugs and the Definition of Dis- ease, Baltimore, Johns Hopkins University Press, 2007; Timmermann, C., ‘To treat or not to treat: Drug research and the changing nature of essential hypertension’, Schlich, T.
    [Show full text]
  • Standard Methods for Fungal Brood Disease Research Métodos Estándar Para La Investigación De Enfermedades Fúngicas De La Cr
    Journal of Apicultural Research 52(1): (2013) © IBRA 2013 DOI 10.3896/IBRA.1.52.1.13 REVIEW ARTICLE Standard methods for fungal brood disease research Annette Bruun Jensen1*, Kathrine Aronstein2, José Manuel Flores3, Svjetlana Vojvodic4, María 5 6 Alejandra Palacio and Marla Spivak 1Department of Plant and Environmental Sciences, University of Copenhagen, Thorvaldsensvej 40, 1817 Frederiksberg C, Denmark. 2Honey Bee Research Unit, USDA-ARS, 2413 E. Hwy. 83, Weslaco, TX 78596, USA. 3Department of Zoology, University of Córdoba, Campus Universitario de Rabanales (Ed. C-1), 14071, Córdoba, Spain. 4Center for Insect Science, University of Arizona, 1041 E. Lowell Street, PO Box 210106, Tucson, AZ 85721-0106, USA. 5Unidad Integrada INTA – Facultad de Ciencias Ags, Universidad Nacional de Mar del Plata, CC 276,7600 Balcarce, Argentina. 6Department of Entomology, University of Minnesota, St. Paul, Minnesota 55108, USA. Received 1 May 2012, accepted subject to revision 17 July 2012, accepted for publication 12 September 2012. *Corresponding author: Email: [email protected] Summary Chalkbrood and stonebrood are two fungal diseases associated with honey bee brood. Chalkbrood, caused by Ascosphaera apis, is a common and widespread disease that can result in severe reduction of emerging worker bees and thus overall colony productivity. Stonebrood is caused by Aspergillus spp. that are rarely observed, so the impact on colony health is not very well understood. A major concern with the presence of Aspergillus in honey bees is the production of airborne conidia, which can lead to allergic bronchopulmonary aspergillosis, pulmonary aspergilloma, or even invasive aspergillosis in lung tissues upon inhalation by humans. In the current chapter we describe the honey bee disease symptoms of these fungal pathogens.
    [Show full text]
  • Tinea Capitis 2014 L.C
    BJD GUIDELINES British Journal of Dermatology British Association of Dermatologists’ guidelines for the management of tinea capitis 2014 L.C. Fuller,1 R.C. Barton,2 M.F. Mohd Mustapa,3 L.E. Proudfoot,4 S.P. Punjabi5 and E.M. Higgins6 1Department of Dermatology, Chelsea & Westminster Hospital, Fulham Road, London SW10 9NH, U.K. 2Department of Microbiology, Leeds General Infirmary, Leeds LS1 3EX, U.K. 3British Association of Dermatologists, Willan House, 4 Fitzroy Square, London W1T 5HQ, U.K. 4St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust, St Thomas’ Hospital, Westminster Bridge Road, London SE1 7EH, U.K. 5Department of Dermatology, Hammersmith Hospital, 150 Du Cane Road, London W12 0HS, U.K. 6Department of Dermatology, King’s College Hospital, Denmark Hill, London SE5 9RS, U.K. 1.0 Purpose and scope Correspondence Claire Fuller. The overall objective of this guideline is to provide up-to- E-mail: [email protected] date, evidence-based recommendations for the management of tinea capitis. This document aims to update and expand Accepted for publication on the previous guidelines by (i) offering an appraisal of 8 June 2014 all relevant literature since January 1999, focusing on any key developments; (ii) addressing important, practical clini- Funding sources cal questions relating to the primary guideline objective, i.e. None. accurate diagnosis and identification of cases; suitable treat- ment to minimize duration of disease, discomfort and scar- Conflicts of interest ring; and limiting spread among other members of the L.C.F. has received sponsorship to attend conferences from Almirall, Janssen and LEO Pharma (nonspecific); has acted as a consultant for Alliance Pharma (nonspe- community; (iii) providing guideline recommendations and, cific); and has legal representation for L’Oreal U.K.
    [Show full text]
  • Therapies for Common Cutaneous Fungal Infections
    MedicineToday 2014; 15(6): 35-47 PEER REVIEWED FEATURE 2 CPD POINTS Therapies for common cutaneous fungal infections KENG-EE THAI MB BS(Hons), BMedSci(Hons), FACD Key points A practical approach to the diagnosis and treatment of common fungal • Fungal infection should infections of the skin and hair is provided. Topical antifungal therapies always be in the differential are effective and usually used as first-line therapy, with oral antifungals diagnosis of any scaly rash. being saved for recalcitrant infections. Treatment should be for several • Topical antifungal agents are typically adequate treatment weeks at least. for simple tinea. • Oral antifungal therapy may inea and yeast infections are among the dermatophytoses (tinea) and yeast infections be required for extensive most common diagnoses found in general and their differential diagnoses and treatments disease, fungal folliculitis and practice and dermatology. Although are then discussed (Table). tinea involving the face, hair- antifungal therapies are effective in these bearing areas, palms and T infections, an accurate diagnosis is required to ANTIFUNGAL THERAPIES soles. avoid misuse of these or other topical agents. Topical antifungal preparations are the most • Tinea should be suspected if Furthermore, subsequent active prevention is commonly prescribed agents for dermatomy- there is unilateral hand just as important as the initial treatment of the coses, with systemic agents being used for dermatitis and rash on both fungal infection. complex, widespread tinea or when topical agents feet – ‘one hand and two feet’ This article provides a practical approach fail for tinea or yeast infections. The pharmacol- involvement. to antifungal therapy for common fungal infec- ogy of the systemic agents is discussed first here.
    [Show full text]
  • Therapies for Common Cutaneous Fungal Infections
    MedicineToday 2014; 15(6): 35-47 PEER REVIEWED FEATURE 2 CPD POINTS Therapies for common cutaneous fungal infections KENG-EE THAI MB BS(Hons), BMedSci(Hons), FACD Key points A practical approach to the diagnosis and treatment of common fungal • Fungal infection should infections of the skin and hair is provided. Topical antifungal therapies always be in the differential are effective and usually used as first-line therapy, with oral antifungals diagnosis of any scaly rash. being saved for recalcitrant infections. Treatment should be for several • Topical antifungal agents are typically adequate treatment weeks at least. for simple tinea. • Oral antifungal therapy may inea and yeast infections are among the dermatophytoses (tinea) and yeast infections be required for extensive most common diagnoses found in general and their differential diagnoses and treatments disease, fungal folliculitis and practice and dermatology. Although are then discussed (Table). tinea involving the face, hair- antifungal therapies are effective in these bearing areas, palms and T infections, an accurate diagnosis is required to ANTIFUNGAL THERAPIES soles. avoid misuse of these or other topical agents. Topical antifungal preparations are the most • Tinea should be suspected if Furthermore, subsequent active prevention is commonly prescribed agents for dermatomy- there is unilateral hand just as important as the initial treatment of the coses, with systemic agents being used for dermatitis and rash on both fungal infection. complex, widespread tinea or when topical agents feet – ‘one hand and two feet’ This article provides a practical approach fail for tinea or yeast infections. The pharmacol- involvement. to antifungal therapy for common fungal infec- ogy of the systemic agents is discussed first here.
    [Show full text]
  • DERMATOPHYTOSIS ( Ti Ri ) ( Ti Ri ) (=Tinea = Ringworm)
    DERMATOPHYTOSIS (Ti(=Tinea = Ringworm) IInfection of the skin, hair or nails caused by a group of keratinophilic fungi, called dermatophytes ¨ Microsporum Hair, skin ¨ Epidermophyton Skin, nail ¨ TTihrichoph htyton HHiair, skin, nail DERMATOPHYTES IDigest keratin by their keratinases IResistant to cycloheximide IClassified into three groups depending on their usual habitat All three dermatoppyhytes contain virulence factors that allow them to invade the skin, hair, and nails Keratinases Elastase Proteinases DERMATOPHYTES IANTROPOPHILIC Trichophyton rubrum... IGEOPHILIC Microsporum gypseum... IZOOPHILIC Microsporum canis: cats and dogs Microsporum nanum: swine Trichophyton verrucosum: horse and swine… Zoophilic dermatophytes Microscopic characteristics of dermatophyte genera Microsporum Epidermophyton Trichophyton DERMATOPHYTOSIS PhPathogenesi s and Immuni ty IContact and trauma IMoisture ICrowded living conditions ICellular immunodeficiency Æ(()chronic inf.) IReRe--infectioninfection is possible (but, larger inoculum is needed, the course is shorter ) DERMATOPHYTOSIS Clllinical Cllfassification IInfection is named according to the anatomic location involved: a. Tinea barbae e. Tinea pedis (Athlete’ s foot) b. Tinea corporis f. Tinea manuum c. Tinea capitis g. Tinea unguium d. Tinea cruris (Jock itch) DERMATOPHYTOSIS Clini ca l manifestat ions ISkin: Circular, dry, erythematous, scaly, itchy lesions IHair: Typical lesions,”kerion”, scarring, “l“alopeci i”a” INail: Thickened,,fm, deformed, friable, discolored nails, subungual debris accumulation IFavus (Tinea favosa) DERMATOPHYTOSIS TiiTransmission IClose human contact ISharing clothes, combs, brushes, towels, bedsheets... (Indirect ) IAnimalAnimal--toto--humanhuman contact (Zoophilic) DERMATOPHYTOSIS Diagnos is I. Clllinical Appearance Wood lamp (UV, 365 nm) II. Lab A. Direct microscopic examination ((1010--2525%% KOH) Ectothrix/endothrix/favic hair DERMATOPHYTOSIS Diagnos is B. Culture Mycobiotic agar Sabdbouraud dextrose agar DERMATOPHYTES Iden tifica tion A. Colony characteristics B.
    [Show full text]
  • Lecture 3 Dermatology
    Lecture 5 Dermatology Dr khaled sobhy Tinea Capitis (not OTC) • Also called ringworm of the scalp • Diagnosis depend on location and presentation Presentation: • 1- most common: circular patches of dry scaly skin with hair loss. The hair is cut short 2-3 mm above the surface. Scalp is non inflamed • 2- black dot ringworm: are rounded or oval scaly patches with hair broken at the scalp giving the characteristic black dot appearance. Scalp is non inflamed 2 Tinea Capitis (not OTC) • 3- keroin: in which the scalp is inflamed producing exudates and abscess or pustules (secondary bacterial infection) progress to crust after healing leaving scare with permanent hair loss (hair follicle is unable to regenerate • 4- Favus : waxy appearance of scalp due to excessive scales with cup shaped crust around several hairs which progress to involve the entire scalp with bad odor of the scalp 3 Tinea capitis Black dot ring worm Keroin Favus Treatment (not OTC) • Due to risk of permanent hair loss patients should be rapidly referred to physician • Systemic antifungal therapy should be used: • Grisofulvin (first choice for 8 weeks) • Imidazole (itraconazole , fluconazole) for 8 weeks • Terbinafine (for 4 weeks) • Topical antifungal as shampoo should be added 7 Systemic Antifungal Topical treatment Candidal Infections - It is caused by yeast-like fungus (Candida albicans) Clinical forms: Candidal paronychia, Oral candidal thrush, Candidal intertrigo, and Candidal vulvovaginitis. Treatment of Canadidal infection -Nystatin topically -Topical or systemic imidazoles -Gentian violet 1-2% Most candidal infections resolve without further problems yeast infections usually clear in 1-2 weeks. 10 Candidal vulvovaginitis Vaginal yeast infection, also known as vaginal thrush.
    [Show full text]
  • Immunity Against Fungi
    Immunity against fungi Michail S. Lionakis, … , Iliyan D. Iliev, Tobias M. Hohl JCI Insight. 2017;2(11):e93156. https://doi.org/10.1172/jci.insight.93156. Review Pathogenic fungi cause a wide range of syndromes in immune-competent and immune-compromised individuals, with life-threatening disease primarily seen in humans with HIV/AIDS and in patients receiving immunosuppressive therapies for cancer, autoimmunity, and end-organ failure. The discovery that specific primary immune deficiencies manifest with fungal infections and the development of animal models of mucosal and invasive mycoses have facilitated insight into fungus-specific recognition, signaling, effector pathways, and adaptive immune responses. Progress in deciphering the molecular and cellular basis of immunity against fungi is guiding preclinical studies into vaccine and immune reconstitution strategies for vulnerable patient groups. Furthermore, recent work has begun to address the role of endogenous fungal communities in human health and disease. In this review, we summarize a contemporary understanding of protective immunity against fungi. Find the latest version: https://jci.me/93156/pdf REVIEW Immunity against fungi Michail S. Lionakis,1 Iliyan D. Iliev,2 and Tobias M. Hohl3 1Fungal Pathogenesis Unit, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA. 2Jill Roberts Institute for Research in IBD, Department of Medicine, Weill Cornell Medical College, New York, New York, USA. 3Infectious Disease Service, Department of Medicine, and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Pathogenic fungi cause a wide range of syndromes in immune-competent and immune- compromised individuals, with life-threatening disease primarily seen in humans with HIV/AIDS and in patients receiving immunosuppressive therapies for cancer, autoimmunity, and end-organ failure.
    [Show full text]
  • Fungal Infections
    Fungal infections Natural defence against fungi y Fatty acid content of the skin y pH of the skin, mucosal surfaces and body fluids y Epidermal turnover y Normal flora Predisposing factors y Tropical climate y Manual labour population y Low socioeconomic status y Profuse sweating y Friction with clothes, synthetic innerwear y Malnourishment y Immunosuppressed patients HIV, Congenital Immunodeficiencies, patients on corticosteroids, immunosuppressive drugs, Diabetes Fungal infections: Classification y Superficial cutaneous: y Surface infections eg. P.versicolor, Dermatophytosis, Candidiasis, T.nigra, Piedra y Subcutaneous: Mycetoma, Chromoblastomycosis, Sporotrichosis y Systemic: (opportunistic infection) Histoplasmosis, Candidiasis Of these categories, Dermatophytosis, P.versicolor, Candidiasis are common in daily practice Pityriasis versicolor y Etiologic agent: Malassezia furfur Clinical features: y Common among youth y Genetic predisposition, familial occurrence y Multiple, discrete, discoloured, macules. y Fawn, brown, grey or hypopigmented y Pinhead sized to large sheets of discolouration y Seborrheic areas, upper half of body: trunk, arms, neck, abdomen. y Scratch sign positive PITYRIASIS VERSICOLOR P.versicolor : Investigations y Wood’s Lamp examination: y Yellow fluorescence y KOH preparation: Spaghetti and meatball appearance Coarse mycelium, fragmented to short filaments 2-5 micron wide and up to 2-5 micron long, together with spherical, thick-walled yeasts 2-8 micron in diameter, arranged in grape like fashion. P.versicolor: Differential diagnosis y Vitiligo y Pityriasis rosea y Secondary syphilis y Seborrhoeic dermatitis y Erythrasma y Melasma Treatment P. versicolor Topical: y Ketoconazole , Clotrimazole, Miconazole, Bifonazole, Oxiconazole, Butenafine,Terbinafine, Selenium sulfide, Sodium thiosulphate Oral: y Fluconazole 400mg single dose y Ketoconazole 200mg OD x 14days yGriseofulvin is NOT effective.
    [Show full text]
  • Update on Therapy for Superficial Mycoses: Review Article Part I * Atualização Terapêutica Das Micoses Superficiais: Artigo De Revisão Parte I
    764 REVIEW s Update on therapy for superficial mycoses: review article part I * Atualização terapêutica das micoses superficiais: artigo de revisão parte I Maria Fernanda Reis Gavazzoni Dias1 Maria Victória Pinto Quaresma-Santos2 Fred Bernardes-Filho2 Adriana Gutstein da Fonseca Amorim3 Regina Casz Schechtman4 David Rubem Azulay5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20131996 Abstract: Superficial fungal infections of the hair, skin and nails are a major cause of morbidity in the world. Choosing the right treatment is not always simple because of the possibility of drug interactions and side effects. The first part of the article discusses the main treatments for superficial mycoses - keratophytoses, dermatophy- tosis, candidiasis, with a practical approach to the most commonly-used topical and systemic drugs , referring also to their dosage and duration of use. Promising new, antifungal therapeutic alternatives are also highlighted, as well as available options on the Brazilian and world markets. Keywords: Antifungal agents; Dermatomycoses; Mycoses; Therapeutics; Tinea; Yeasts Resumo: As infecções fúngicas superficiais dos cabelos, pele e unhas representam uma causa importante de mor- bidade no mundo. O tratamento nem sempre é simples, havendo dificuldade na escolha dos esquemas terapêu- ticos disponíveis na literatura, assim como suas possíveis interações medicamentosas e efeitos colaterais. A pri- meira parte do trabalho aborda os principais esquemas terapêuticos das micoses superficiais - ceratofitoses, der- matofitoses, candidíase - possibilitando a consulta prática das drogas tópicas e sistêmicas mais utilizadas, sua dosagem e tempo de utilização. Novas possibilidades terapêuticas antifungicas também são ressaltadas, assim como as apresentações disponíneis no mercado brasileiro e mundial. Palavras-chave: Antifúngicos; Dermatomicoses; Leveduras; Micoses; Terapêutica; Tinha Received on 19.07.2012.
    [Show full text]
  • Fungal Diseases of Poultry
    Fungal Diseases of Poultry 1. Avian aspergillosis. 2. Candidiasis. 3. Favus. 4. Dactylariosis. Brooder pneumonia, mycotic pneumonia, pneumomycosis, Bronchomycosis Definition: ⚫ An infectious disease ⚫ Mainly of respiratory tract of birds ⚫ Characterized by ⚫ Acute miliary infection of the lungs in young birds ⚫ Chronic air sac infection in adults ⚫ Respiratory distress, central nervous dysfunction, sleepiness, inappetance emaciation, conjunctivitis and cloudy eyes can be seen Etiology ⚫ Many species of genus Aspergillus which is composed of approximately 600 species. ⚫ Mainly Aspergillus fumigatus. Other species like A. flavus, A. nidulans, A. glaucus, A. niger, and A. candidus ⚫ Family Moniliaceae ⚫ Characteristics: ⚫ Commonly occur in decaying vegetative matter, soil & feed grains ⚫ The fungi grow on sabaroud dextrose agar media with antibiotics at room temperature 37C. Colonies are green to bluish green at first and darken with age to appear almost black. Sabouraud dextrose agar ⚫ Aspergillus species are common in the environment. Spores often become airborne in dry windy weather spreading from one location to another. Spores can enter an individual and develop in the respiratory system, lungs, eyes, and ears. ⚫ A. Fumigatus has a toxin which is hemotoxic, neurotoxic, and histotoxic. ⚫ Aspergillosis can be fatal, especially to those with immunodeficiency. its opportunistic pathogen. ASPERGILLUS This micrograph depicts the histologic features of aspergillus including the presence of conidial heads Susceptibility: ⚫ Species: all species of birds probably are susceptible. The disease develops in the brooder stage in chicks, quails, pheasants, turkeys, pigeons, parrots, etc... ⚫ Age: chicks below 10 days of age but may affect birds up to the age of 10 weeks. Chicks below 3 days of age are highly susceptible.
    [Show full text]